New pain block may cut morphine use after lung surgery
NCT ID NCT07367581
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests two different nerve blocks to control pain after lung cancer surgery. 70 adults will receive either a costotransverse foramen block or a thoracic paravertebral block, both using the numbing drug bupivacaine. The goal is to see which block reduces the need for morphine and improves pain relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bupivacaine
- What this could lead to
- If one block works better, it could mean less pain and less morphine after lung surgery, helping patients recover faster.
- What could go wrong
- This is a small, early-stage trial with only 70 people. The results may not apply to everyone, and nerve blocks carry small risks like infection or bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COSTOTRANSVERSE FORAMEN BLOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cairo University
RECRUITINGCairo, 12613, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Your Tumor's DNA might predict immunotherapy success
- Can a new PET tracer light up hidden cancers?
- Fellow veterans may hold the key to earlier lung cancer detection